Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-03-03

FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for Tegretol (carbamazepine) from Novartis Pharmaceuticals Corporation, authorizing changes to the product labeling. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TEGRETOL (CARBAMAZEPINE)

Snippet

SUPPL AP for TEGRETOL (CARBAMAZEPINE)